HomeCompareRHHBF vs NNN

RHHBF vs NNN: Dividend Comparison 2026

RHHBF yields 2.28% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RHHBF wins by $3.2K in total portfolio value
10 years
RHHBF
RHHBF
● Live price
2.28%
Share price
$410.32
Annual div
$9.37
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.7K
Annual income
$1,518.26
Full RHHBF calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — RHHBF vs NNN

📍 RHHBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRHHBFNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RHHBF + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RHHBF pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RHHBF
Annual income on $10K today (after 15% tax)
$194.20/yr
After 10yr DRIP, annual income (after tax)
$1,290.52/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, NNN beats the other by $938.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RHHBF + NNN for your $10,000?

RHHBF: 50%NNN: 50%
100% NNN50/50100% RHHBF
Portfolio after 10yr
$27.1K
Annual income
$2,070.47/yr
Blended yield
7.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

RHHBF
Analyst Ratings
3
Buy
5
Hold
1
Sell
Consensus: Hold
Altman Z
5.3
Piotroski
6/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RHHBF buys
0
NNN buys
0
No recent congressional trades found for RHHBF or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRHHBFNNN
Forward yield2.28%5.66%
Annual dividend / share$9.37$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR17%8.6%
Portfolio after 10y$28.7K$25.5K
Annual income after 10y$1,518.26$2,622.67
Total dividends collected$7.3K$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldHold

Year-by-year: RHHBF vs NNN ($10,000, DRIP)

YearRHHBF PortfolioRHHBF Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$10,967$267.32$10,735$614.96+$232.00RHHBF
2$12,056$320.57$11,572$708.43+$484.00RHHBF
3$13,285$385.32$12,531$819.53+$754.00RHHBF
4$14,679$464.29$13,633$952.29+$1.0KRHHBF
5$16,268$560.96$14,909$1,111.84+$1.4KRHHBF
6$18,086$679.77$16,392$1,304.77+$1.7KRHHBF
7$20,178$826.39$18,129$1,539.52+$2.0KRHHBF
8$22,599$1,008.16$20,173$1,827.08+$2.4KRHHBF
9$25,416$1,234.62$22,597$2,181.81+$2.8KRHHBF
10$28,713$1,518.26$25,491$2,622.67+$3.2KRHHBF

RHHBF vs NNN: Complete Analysis 2026

RHHBFStock

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). The company was founded in 1896 and is headquartered in Basel, Switzerland.

Full RHHBF Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this RHHBF vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RHHBF vs SCHDRHHBF vs JEPIRHHBF vs ORHHBF vs KORHHBF vs MAINRHHBF vs ADCRHHBF vs EPRTRHHBF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.